Does Pantoprazole Sodium Granules Interact with Erlotinib?
CDI records a moderate classification for Pantoprazole Sodium Granules and Erlotinib. The stored summary is: Pantoprazole reduces gastric pH which may decrease absorption of erlotinib. The mechanism involves drugs dependent on gastric ph for absorption. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Erlotinib Class
- Kinase Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Drugs dependent on gastric pH for absorption
What To Tell Your Doctor or Pharmacist
If you are taking Pantoprazole Sodium Granules and your doctor is considering prescribing Erlotinib (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider